A Comprehensive Screening And Treatment Model For Reducing Disparities In Hepatitis B
Henry Pollack(New York University), Simona C. Kwon(Hepatitis B Foundation), Kejia Wan(United Nations Office for the Coordination of Humanitarian Affairs), Laura C. Wyatt(New York University), Kay Chun(Community Health Center), Su Wang(Rutgers, The State University of New Jersey), Chia-hui Peng(Peng Huanwu Center for Fundamental Theory), Thomas Tsang(Public Health Laboratory), Chau Trinh‐Shevrin(Community Health Center)
Cited by 54
Related Papers
Zika Virus NS4A and NS4B Proteins Deregulate Akt-mTOR Signaling in Human Fetal Neural Stem Cells to Inhibit Neurogenesis and Induce Autophagy
|Cell stem cell|2016|565
Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
|Journal of Hepatology|2019|364
Neonatal Chimerization with Human Glial Progenitor Cells Can Both Remyelinate and Rescue the Otherwise Lethally Hypomyelinated Shiverer Mouse
|Cell stem cell|2008|329